***********************************
Brakke Consulting’s Animal Health News & Notes for June 28, 2024
Copyright © Brakke Consulting
Editor: Lynn Fondon DVM MBA
************************************
IN THE NEWS:
Brakke Consulting News
Simon Hall Joins Brakke Consulting
Transaction Insights seminar
Earnings News
General Mills
Other News
Chou2 Pharma
Elanco
Evette
Fear Free
Jaguar Health
Krista.ai
Leonard Green & Partners
MedVet
Merck
Petbuddy Group
Thrive Pet Foods
Zomedica
*****************************************
Brakke Consulting
Simon Hall Joins Brakke Team
Brakke Consulting welcomes Simon Hall as a Senior Consultant. With 32 years in the animal health industry, Hall brings extensive experience in feed additives, nutritional health, and food safety in livestock and poultry, both in the US and internationally. His expertise will assist Brakke clients in product assessments and guiding products from development to commercialization. Hall also has a strong background in sales, marketing, and commercial operations across various company sizes.
Brakke Consulting President Dr. Robert Jones states, “It is not very often that we find someone with Simon’s experiences and successes in product development, sales, marketing, and new business development in the livestock and poultry industry. We are very happy to have him on our team.” Contact Mr. Hall at shall@brakkeconsulting.com.
*********************************************
EARNINGS NEWS RELEASES
- General Mills, Inc. reported results for the fiscal year ended May 26, 2024. Pet segment net sales were down 4% to $2.4 billion. Segment operating profit increased 9% to $486 million. (company press release)
**************************************
COMPANY NEWS RELEASES
- Merck Animal Health announced USDA approval of Nobivac NXT Canine Flu H3N2, the first and only RNA-particle technology vaccine for canine influenza. The product is expected to be available at veterinary clinics and hospitals nationwide late this summer. (company press release)
- Elanco Animal Health Incorporated announced updates to the expected FDA approval timelines for Zenrelia (a JAK Inhibitor targeting control of pruritus and atopic dermatitis in dogs) and Credelio Quattro (a broad spectrum parasiticide). The company now anticipates a U.S. launch for Zenrelia in the fourth quarter of 2024; the expected approval for Credelio Quattro is in the fourth quarter of 2024, with U.S. launch expected in the first quarter of 2025. (company press release)
- Zomedica announced the commercial launch of its second equine focused assay – Cortisol for equine serum – for the point-of-care Truforma diagnostic platform. (biospace.com)
- Jaguar Health announced that the Company received formal notice from The Nasdaq Stock Market LLC that Jaguar has regained compliance with Nasdaq’s minimum bid price requirement. (seekingalpha)
- MedVet LLC, a leading provider of emergency and specialty veterinary care, announced that it has received a minority capital investment from Leonard Green & Partners, L.P. and a senior term loan from Oak Hill Advisors. These investments will help MedVet accelerate its next stage of growth, provide minority shareholders a successful exit from their 2019 investment, and provide partial liquidity for some of MedVet’s employee owners. (globenewswire)
- Fear Free and Chou2 Pharma, a pet supplement company, announced a partnership to educate and provide tools for pet parents, pet professionals, and veterinarians in support of calmer, safer environments for animals. (company press release)
- Evette, a veterinary relief staffing agency, announced its integration with ai, a leader in enterprise-wide AI orchestration. (morningstar.com)
- UK Petbuddy Group (PBG) has acquired UK-based freeze-dried diets company Thrive Pet Foods. Financial terms were not disclosed. (Pet Business)
*********************************************
Brakke Consulting
Transaction Insights: Unlocking the Secrets to Successful Business Deals in Animal Health
Wednesday, August 28th | Kansas City
Are you seeking to navigate the complex landscape of buying and selling businesses or technology in the animal health and nutrition industry? Given the success of last year’s relaunch, we are excited to announce our educational transaction seminar for 2024, tailored specifically for animal health professionals.
It’s more than just due diligence – we will help you unlock the secrets to successful deals in animal health. This one-day comprehensive seminar is designed to equip you with the knowledge, tools, and strategies to make informed decisions and to successfully manage a transaction in the animal health industry.
Presenters include Senior Brakke Consultants Jim Kroman, Paul Casady, and Randy Freides. The Seminar will be held on Wednesday August 28th, immediately following the KCAHC Animal Health Summit in Kansas City. Click here to sign up today and receive a discount.
For more information, contact Amanda McDavid at amcdavid@brakkeconsulting.com or 336.396.3916.
*********************************************
ANIMAL HEALTH STOCK PRICE TRACKER
***********************************
ANIMAL HEALTH NEWS
- WORLD – FELINE HEALTH The International Society of Feline Medicine and the American Association of Feline Practitioners have created the 2024 ISFM/AAFP Consensus Guidelines on the Long-Term Use of NSAIDs in cats to provide veterinary practitioners with decision-making tools for prescribing NSAIDs in situations of chronic pain to minimize adverse effects and optimize pain management for their feline patients. (AVMA news)
- US – DRUG REGULATION The FDA announced the availability of final guidance for industry (GFI) #276 entitled “Effectiveness of Anthelmintics: Specific Recommendations for Products Proposed for the Prevention of Heartworm Disease in Dogs.” (FDA)
- US – DRUG REGULATION The FDA’s Center for Veterinary Medicine and the European Medicines Agency announced recent updates to the Parallel Scientific Advice program for new animal drug products, which allows for animal drug sponsors to engage in concurrent scientific conversation with both agencies, the FDA and the EMA, on key issues during the development phase of new animal drug products. Recent updates include an addition of a trilateral meeting with the sponsor and both agencies; defined timelines for scientific advice and feedback; and preliminary written feedback to the sponsor. (FDA)
- US – VETERINARY SCHOOLS Midwestern University, which graduated its inaugural veterinary class in 2018 in Glendale, Arizona, intends to launch a second DVM program. The new one would open in Downers Grove, Illinois, as soon as 2026 if accreditation is granted. (Todays Veterinary Business)
************************************
BRAKKE CONSULTING VIEWPOINT
I had the pleasure to attend the AVMA Convention in Austin last weekend, along with around 7,500 veterinarians, staff, and exhibitors. There was great traffic in the Exhibit Hall and a wide variety of educational opportunities available. Congratulations to the AVMA staff on another successful meeting.
At one of those educational lectures Brakke’s own John Volk, along with Warda Elakkari of Merck Animal Health, presented some of the results of the 2023 Merck Veterinary Well Being Study. This 1-hour seminar focused on the well-being of veterinary staff (previous presentations at VMX and WVC focused on veterinarian well-being). Veterinary teams are critical to the success of veterinary practices, and every practice owner and industry partner should be actively investing in their well-being. If you’d like more information about the results, you can find it on Merck’s dedicated website.
Lynn Fondon
***********************************
YOUR VIEW
Last week, we asked how you like to read while relaxing on vacation. More than half of you (53%) said you like physical books; 16% use e-readers like Kindle; 14% read on your smartphone, tablet or laptop; and 9% listen to audiobooks. Only 8% said you disconnect and don’t read on vacation.
This week
Keeping with the summer vacation theme, tell us about your summer vacation plans.
English (United States) 
Portuguese